$1.30
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NasdaqCM:BRTX
BioRestorative Therapies Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| BAX | Baxter International Inc | NYSE | Hold | $35.25 | $44.86 | 0.00% | 5 | $17.96B |
| VCEL | Vericel | NasdaqGM | Buy | $48.35 | $42.58 | 0.00% | 0 | $2.36B |
| GERN | Geron | NasdaqGS | Outperform | $3.81 | $4.83 | 0.00% | 1 | $2.30B |
| LCTX | Lineage Cell Therapeutics | NYSEAM | Outperform | $1.08 | $5.40 | 0.00% | 1 | $220.89M |
| MSB | Mesoblast | ASX | Buy | $1.09 | $0.69 | 0.00% | 0 | $299.37M |
| LSTA | Lisata Therapeutics | NasdaqCM | Buy | $2.77 | $16.00 | 0.00% | 2 | $22.85M |
| PSTV | Plus Therapeutics | NasdaqCM | Buy | $2.24 | $11.00 | 0.00% | 2 | $9.92M |
